Skip to main content
  • Register
  • Help
  • Contact us

Ontrak Inc (OTRK) USD0.0001

Sell:$31.69 Buy:$31.81 Change: $3.10 (10.82%)
Market closed |  Prices as at close on 7 May 2021 | Switch to live prices |
Sell:$31.69
Buy:$31.81
Change: $3.10 (10.82%)
Market closed |  Prices as at close on 7 May 2021 | Switch to live prices |
Sell:$31.69
Buy:$31.81
Change: $3.10 (10.82%)
Market closed |  Prices as at close on 7 May 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Ontrak, Inc., formerly Catasys, Inc., is an artificial intelligence (AI)-powered and telehealth-enabled, virtualized outpatient healthcare treatment company. Its Ontrak PRE (Predict-Recommend-Engage) platform predicts people whose chronic disease will improve with behavior change, recommends care pathways that people are willing to follow, and engages people who aren’t getting the care they need. The Company’s integrated, technology-enabled OnTrak solution, which is designed to identify and treat members with behavioral conditions that cause or exacerbate chronic medical conditions such as diabetes, hypertension, coronary artery disease, chronic obstructive pulmonary disease, and congestive heart failure. OnTrak integrates evidence-based psychosocial and medical interventions delivered either in-person or via telehealth, along with care coaching and in-market Community Care Coordinators who address the social and environmental determinants of health, including loneliness.

Contact details

Address:
2120 COLORADO AVE, SUITE 230
SANTA MONICA
90404
United States
Telephone:
+1 (310) 4444300
Website:
catasys.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
OTRK
ISIN:
US6833731044
Market cap:
$547.00 million
Shares in issue:
17.74 million
Sector:
Health Care Services
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Terren Peizer
    Chairman of the Board
  • Curtis Medeiros
    President, Chief Operating Officer
  • Jonathan Mayhew
    Chief Executive Officer
  • Brandon LaVerne
    Chief Financial Officer
  • Daniel Prewitt
    Senior Vice President - Sales
  • Robert Newton
    General Counsel, Secretary
  • Carol Murdock
    Chief Commercial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.